Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Norkrans

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1995
Intestinal immune responsiveness in HIV-infected individualsK Eriksson, A Kilander, L Hagberg, et al.
Scandinavian Journal of Gastroenterology|April 1, 1982
Clearance of hepatitis B e-antigen in chronic hepatitis B infectionG Norkrans, J Lindberg, G Frösner, et al.
Scandinavian Journal of Infectious Diseases|August 14, 1999
Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis CO Weiland, J H Braconier, A Frydén, et al.
Lancet (London, England)|November 29, 1986
Isolation of human immunodeficiency virus from cerebrospinal fluid of antibody-positive virus carrier without neurological symptomsF Chiodi, B Asjö, E M Fenyö, et al.
Lancet (London, England)|January 24, 1998
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study GroupO Reichard, G Norkrans, A Frydén, et al.
Lakartidningen|September 2, 1981
[Viral hepatitis--a problem under control?]E Nordenfelt, S Iwarson, B Christenson, et al.
Scandinavian Journal of Infectious Diseases|March 10, 2001
Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-responseJ Westin, M Lindh, N Nenonen, et al.
Lancet (London, England)|October 2, 1993
Zidovudine-resistant variants of HIV-1 in brainM Di Stefano, G Norkrans, F Chiodi, et al.
Journal of Medical Virology|June 13, 1998
Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriersM Lindh, C Gustavson, K Mårdberg, et al.
Scandinavian Journal of Infectious Diseases|March 5, 1999
Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis CO Reichard, G Norkrans, A Frydén, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Advances in Experimental Medicine and Biology|January 1, 1995
Intestinal immune responsiveness in HIV-infected individualsK Eriksson, A Kilander, L Hagberg, et al.
Scandinavian Journal of Gastroenterology|April 1, 1982
Clearance of hepatitis B e-antigen in chronic hepatitis B infectionG Norkrans, J Lindberg, G Frösner, et al.
Scandinavian Journal of Infectious Diseases|August 14, 1999
Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis CO Weiland, J H Braconier, A Frydén, et al.
Lancet (London, England)|November 29, 1986
Isolation of human immunodeficiency virus from cerebrospinal fluid of antibody-positive virus carrier without neurological symptomsF Chiodi, B Asjö, E M Fenyö, et al.
Lancet (London, England)|January 24, 1998
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study GroupO Reichard, G Norkrans, A Frydén, et al.
Lakartidningen|September 2, 1981
[Viral hepatitis--a problem under control?]E Nordenfelt, S Iwarson, B Christenson, et al.
Scandinavian Journal of Infectious Diseases|March 10, 2001
Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-responseJ Westin, M Lindh, N Nenonen, et al.
Lancet (London, England)|October 2, 1993
Zidovudine-resistant variants of HIV-1 in brainM Di Stefano, G Norkrans, F Chiodi, et al.
Journal of Medical Virology|June 13, 1998
Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriersM Lindh, C Gustavson, K Mårdberg, et al.
Scandinavian Journal of Infectious Diseases|March 5, 1999
Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis CO Reichard, G Norkrans, A Frydén, et al.
Pageof 17